Personal Information
Organization / Workplace
Washington D.C. Metro Area, MD United States
Occupation
Advisor, Board Member
Industry
Medical / Health Care / Pharmaceuticals
Website
www.ajazhussain.com
About
Self-assured to give assurance to others.
Tags
fda
qbd
pat
quality assurance
quality
us fda
quality by design
pharmaceuticals
pharmaceutical
cgmp
professional development
gmp
biosimilars
design
development
culture
india
generics
system
maturity
nipte
therapeutic equivalence
cmc
risk
data
systems thinking
ich q10
fda cder
integrity
validation
continulal professional development
order of conciousness
generic drugs
21st century cures act
quality control
data integrity
continued process verificaiton
qms
voice of patients
warning letters
usa
behavior
ich q8
good
professional
placebo
pharmaceutical equivalence
process
bioequivalence
real world
adult human develoment
continuous improvement
continuous manufactruing
conciousness
experience
complexity
complex
office of pharmaceutical quality
inspection
evidence
ema
manufacturing
chaos
internal validation
control
systems
regulatory science
ich q9
import alert
compliance
science
interchangeability
substitution
uncertainty
patients
usp
practices
confidence
assurance
industry 4.0
external validaiton
technology
self-authored
form 483
biotechnology
nocebo
affordability
leadership
fda qbd gmp cmc review inspection metrics design r
pharmaceutical technology
management
irrational
vaccine
practice
equivalence
human
statistical
dissolution
smart
orders of conciousness
user experience
expectation
engineering
education
nist
pharmaceutical industry
design thinking
education and training
knowledge managment
excipients
china
breaches
warning letter
managment
cheating
quality management system
biases
pharmacy
industry
ich
methylphenidate
adhd
behavioral economics
pharmaceutical engineering
review
regulation
hussain
professionaljourney
by desing
pharma 4.0
gcp
glp
quantity
qualia
fractals
satisfaction
new prior knowledge
community of knowledge
knowledge management
inequality
customer experience
adhearance
experience economy
pay for performacne
expereince economy
one quality voice
certification
expereince
training
invalidated oos rate
oos
emotions
regualtion
culture of pharmaceutical quality
insight
supply chain
cost of drugs
manufactruing usa
uncertinty
cmc review
risk management
knowledge
big data
sameness
statistics
therapeutic
recalls
value
patient safety
cognitive
drug regulation
formulation sciences
q10
subject by formulation
generic
pharmacist
concerta
challenges
regulatory communication
question based development
voice
pat cppr nipte desing
drug shortages
measurement
calibrator
capability
errors
regulations
medicine
personalized
similarity
blind-spots
eu
comparability
inspections
safety
efficacy
nanotechnology
controls
continuous
understanding
bcs
ajaz
ajaz hussain
regulatory uncertainty
thinking
shepherding
charecterization
advanced analytics
streamline
fda thai
antibodies
monoclonal
change management
pharmacy to the world
health
care
concionsness
sfda
regulator
instiution
intution
resilience
theraputic
generic drug
serialization
dscsa
mangement
revolution
industry 4
pharma 4
process validaiton
validaiton
conciousess
desing
matruity
adulthood
audit
interest
cognative
mandates
law
aloca
post-truth
immaturity
evil
#assurance
#quality
#self-authership
#orders
#laws
#lifespiral
#lifecycle
#control
#regualtion
#capability
#suitability
#development
#maturity
#gcp
#glp
#gmp
#good
#practices
#validaiton
good practices
sustainability
smartfactory
smartphones
emergent
borg
professional journey
supac
ich 14
21st century
best practices
faculty
doe
orders of consciousness
2020
cphi
aaps
new drugs
qulaity
malcom baldridge award
r
residual uncertainty
totality of evidence
weight of evidence
repurposing
theraputics
covid19
pharmaceutical engineering science
consciousness
contol
suitability
capa
special cause
common cause
comission
omission
quality system
constructive development theory
inactive ingredient guide
ich q11
ich q12
leadership development
clinical trials
mrtp
smoking
vaping
harm reduction
personal
pqri
wisdom
information technology
certificaiton
excipientes
ifpac
theraputic equivalence
brand drugs
levothyroxine
emotional processing
rumination
lifecycle
outcome
income
efficiency
ecology
one voice
comlexity
availability
process validation
import alerts
product withdrawals
epistemology
theory of knowledge
deming
adult development
inteligence
emotional
chemical
biotech
branding
industrial engineering
msc
adpharming
alcoa
badi
metrics
real-time controls
socialized mind
selfconfidence
happiness
interchnageability
email marketing
process analytical technology
globalization
makeing in america
software
part 11
advice
ajaz s. hussain
quality of drugs
trump
transformation
president-elect
niimbl
crtitical path
nasal sprary
bioequivalence generic
snakes and ladders
rumi
six blind men and the elephant
angle of repose
elephant in the dark
tipping point
cmo
qbd. 21st century
patheon
bla
nda
defaults
anda
mhra
who
persistance
passion
six sigma
integrated
qbr
gdufa
trust
epistemic
price pressure
health canada
canada
emerging economies
violations
483
pharma
eurpoe
equivance
quaity
generic< medicine
organizational
blind
reliability
pharmacopoeias
careing
drug utilisation
pharmacokinetics and pharmacodynamics
drug discovery
2014
university
next generation
educating
panjab
oration
biowaiver
food & drug administration
pat team
q9
q8
q12
q11
interaction
replicate
tablets
biosimilar
disorder
lack of effect
ab rating
patient
attention deficit
interchangeeability
complaints
haikudeck
economics
argumentation
integrative thinking
opportunities
breakthrough therapy designation
fdasia
amos tversky
daniel kahneman
malaria
specifications
opq
pharmaceutics
pharmacokinetics
system.
testing
tablet
habits
keystone
fraud
subconscious
fear
econometric
consciously
counterfeits
behaviour
heparin
complinace
real time release
cancer
biomarkers
mechanistic
exposure
response
trial and error
predictive
target
logic
communication
row
profile
failure
thniking
integrative
gauge r&r
epa
factors
preventive
attitude
cluster
perception
poor
norms
team
collaboration
classification
biopharmaceutics
econometrics
chemometrics
pharmacometrics
drugs
devices
intention
risk managment
pragmatic implementation
innovation
quality-by-design
See more
- Presentations
- Documents
- Infographics